← All trials
NCT05552781
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 26, 2022
- Primary completion
- Feb 28, 2025
- Completion date
- Feb 28, 2025
- First posted
- Sep 23, 2022
- Last posted
- Sep 23, 2022
- Enrollment
- 76
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- RedCloud BioLead sponsor
- R&G Pharma Studies Co.,Ltd.Collaborator
- RedCloud BioStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.